Scott Kopetz

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.4Author DataRank

Indexed papers

7in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 7 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 135 papers — median percentile 0. Top paper: “Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer”.

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0217

N/A

3.2DataRank · unranked

126 citations

Nataliya V. Uboha, Meredith S. Pelster, Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman +12 more

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

Nature Medicine(2024)10.1038/s41591-023-02717-6

N/A

2.0DataRank · unranked

94 citations

Marwan Fakih, John H. Strickler, Rona Yaeger, Toshiki Masuishi, Edward Kim +14 more

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer

New England Journal of Medicine(2025)10.1056/nejmoa2501912

N/A

1.9DataRank · unranked

114 citations

Takayuki Yoshino, Lin Shen, Sara Lonardi, Eric Van Cutsem, Cathy Eng +15 more

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2403

N/A

1.5DataRank · unranked

34 citations

Rajyalakshmi Luthra, Yusha Liu, Dzifa Y. Duose, Wonyul Lee, Neelima G. Reddy +20 more

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-024-03443-3

N/A

1.3DataRank · unranked

108 citations

Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim, Harpreet Wasan +10 more

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-006822

N/A

1.3DataRank · unranked

52 citations

Anne Knisely, David Vining, Scott Kopetz, Michael J. Overman, Milind Javle +16 more

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2710

N/A

1.1DataRank · unranked

32 citations

Anthony Dowers, Dongsheng Tu, Derek J. Jonker, Daniel L. Edelstein, Hannah Quinn +11 more

Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00024-x

N/A

1.0DataRank · unranked

51 citations

Jessica Albuquerque, Yuan‐Mao Lin, Brian Anderson, Caleb S O'Connor, B. Rigaud +25 more

Patient-derived micro-organospheres enable clinical precision oncology

Cell stem cell(2022)10.1016/j.stem.2022.04.006

N/A

0.806DataRank · unranked

214 citations

Carolyn Hsu, Zhaohui Wang, Naveen Natesh, Rosemary Millen, Marcos Negrete +32 more

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Cell Reports(2022)10.1016/j.celrep.2022.110993

N/A

0.769DataRank · unranked

168 citations

Oluwadara Coker, Alexey V. Sorokin, Katerina A. Fella, Haley Barnes, Edmond Wong +7 more

Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype

Cancer Research(2024)10.1158/0008-5472.can-23-4070

N/A

0.692DataRank · unranked

21 citations

Jaewon J. Lee, Vittorio Branchi, Kimal Rajapakshe, Zhichao Xu, Naishu Kui +13 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014

Top 31%

0.652DataRank

Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

Nature Biotechnology(2022)10.1038/s41587-022-01342-x

N/A

0.652DataRank · unranked

76 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Yaoyi Dai, Shuai Guo +35 more

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0331

N/A

0.648DataRank · unranked

74 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu-Chin Fu +29 more

A path to translation: How 3D patient tumor avatars enable next generation precision oncology

Cancer Cell(2022)10.1016/j.ccell.2022.09.017

N/A

0.633DataRank · unranked

67 citations

Margarida Barroso, Milan G. Chheda, Hans Clevers, Élena Elez, Salma Kaochar +21 more

BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01241-3

N/A

0.621DataRank · unranked

62 citations

J Wiegand, Peiyi Zhang, Wanyi Hu, Dinesh Thummuri, Vivekananda Budamagunta +9 more

Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status

British journal of surgery(2021)10.1093/bjs/znab086

N/A

0.578DataRank · unranked

46 citations

Scott Kopetz, Hop S. Tran Cao, Elena Panettieri, M De Bellis, Yujiro Nishioka +10 more

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

ESMO Open(2021)10.1016/j.esmoop.2021.100230

N/A

0.564DataRank · unranked

42 citations

S. Greg Call, Helen J. Huang, A.L. Stuckett, Kiran Madwani, Abha Adat +16 more

SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAF V600E-mutant mCRC

Future Oncology(2024)10.2217/fon-2022-1249

N/A

0.561DataRank · unranked

41 citations

Scott Kopetz, Josep Tabernero, Tanios Bekaii-Saab, Julien Taieb, Takayuki Yoshino +6 more

Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis

Advanced Science(2021)10.1002/advs.202004673

N/A

0.533DataRank · unranked

34 citations

Ergang Wang, Jorge Prado Balcazar, Zhenhua Wu, Kun Xiang, Yi Wang +22 more

Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer

British journal of surgery(2022)10.1093/bjs/znac050

N/A

0.529DataRank · unranked

33 citations

Michael G. White, Oliver Peacock, Harmeet Kaur, Sarah Palmquist, Nancy You +6 more

Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention

Gastroenterology(2024)10.1053/j.gastro.2024.01.016

N/A

0.515DataRank · unranked

30 citations

Fahriye Düzağaç, Nan Deng, Laura Reyes-Uribe, Kyle Chang, Wenhui Wu +14 more

Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases

Journal of Gastrointestinal Surgery(2020)10.1007/s11605-020-04866-2

N/A

0.505DataRank · unranked

28 citations

Timothy E. Newhook, Hop S. Tran Cao, Ching‐Wei D. Tzeng, Yun Shin Chun, Thomas A. Aloia +4 more

Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases

Journal of the American College of Surgeons(2021)10.1016/j.jamcollsurg.2021.02.011

N/A

0.505DataRank · unranked

28 citations

Ching‐Wei D. Tzeng, Hop S. Tran Cao, Thomas A. Aloia, Timothy E. Newhook, Michael J. Overman +4 more

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Clinical Colorectal Cancer(2022)10.1016/j.clcc.2022.03.004

N/A

0.489DataRank · unranked

25 citations

Shreya Raghavan, Arvind Dasari, Scott Kopetz, Alisha Bent

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0.477DataRank · unranked

23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers

Nature Communications(2020)10.1038/s41467-020-19141-w

N/A

0.477DataRank · unranked

23 citations

Amjad H. Talukder, Ivy Lai, Rebecca K. Davis, Héctor M. Álvarez, Hervé Tiriac +27 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0.464DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies

Scientific Reports(2020)10.1038/s41598-020-58366-z

N/A

0.464DataRank · unranked

21 citations

Filip Jankú, Sarina A. Piha‐Paul, Kenneth R. Hess, Russell R. Broaddus, Lidong Liu +11 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance

Nature Cancer(2024)10.1038/s43018-024-00781-6

N/A

0.457DataRank · unranked

20 citations

Elizabeth K. Ziemke, Christy L. Frankowski-McGregor, Rachel Mumby, June Hee Chung, Jinju Li +6 more

Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1166

N/A

0.449DataRank · unranked

19 citations

Ajay Kumar Saw, Van K. Morris, Stefania Napolitano, Christopher A. Bristow, Sanjana Srinivasan +11 more

A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyad158

N/A

0.438DataRank · unranked

10 citations

Apostolia M. Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah, Anil K. Sood +7 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0.406DataRank · unranked

14 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more

Resolving clonal substructure from single cell genomic data using CopyKit

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.09.483497

N/A

0.396DataRank · unranked

13 citations

Emi Sei, Junke Wang, Aislyn Schalck, Yun Yan, Alexander Davis +14 more

Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations.

Journal of Clinical Oncology(2017)10.1200/jco.2017.35.15_suppl.3589

N/A

0.360DataRank · unranked

10 citations

Ben Miron, Vijaykumar Holla, Michael J. Overman, Allan Andresson Lima Pereira, Michael Lam +12 more

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo

PLoS ONE(2023)10.1371/journal.pone.0281063

N/A

0.330DataRank · unranked

8 citations

Susmita Ghosh, Reid T. Powell, Jason Roszik, Yongsun Park, Mary Sobieski +6 more

Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0110

N/A

0.330DataRank · unranked

8 citations

Fan Fan, Reid T. Powell, Jason Roszik, Yong Sung Park, Clifford Stephan +8 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0.312DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0262

N/A

0.299DataRank · unranked

6 citations

John V. Heymach, Kenneth L. Kehl, Scott Kopetz, Ken S. Lau, Gregory J. Riely +5 more

NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps232

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps158

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG-GI004/SWOG-S1610).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps260

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Targeted exome-based predictors of patterns of progression of colorectal liver metastasis after percutaneous thermal ablation

British Journal of Cancer(2022)10.1038/s41416-022-02030-y

N/A

0.241DataRank · unranked

4 citations

Yuan‐Mao Lin, Yoshikuni Kawaguchi, Harufumi Maki, A. Kyle Jones, Marco Calandri +6 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0.241DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples

Genome Research(2024)10.1101/gr.278822.123

N/A

0.213DataRank · unranked

3 citations

Xiaoqian Liu, Xuesen Cheng, Yujie Jiang, Shuangxi Ji, Qingnan Liang +14 more

Diverticular disease and cancer risk: More than a gut feeling

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac191

N/A

0.208DataRank · unranked

3 citations

Scott Kopetz, Carrie R. Daniel, Veronika Fedirko

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0.208DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2580

N/A

0.165DataRank · unranked

2 citations

Jonathan M. Loree, Scott Kopetz, Kanwal Raghav

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

Research Square(2024)10.21203/rs.3.rs-4047331/v1

N/A

0.165DataRank · unranked

2 citations

Azam Yazdani, Raúl Méndez-Giráldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi +10 more

Decellularized Extracellular Matrix Scaffolds to Engineer the Dormant Landscape of Microscopic Colorectal Cancer Liver Metastasis

Advanced Healthcare Materials(2025)10.1002/adhm.202501791

N/A

0.165DataRank · unranked

2 citations

Lucia L. Nash, Abigail J. Clevenger, Claudia A. Collier, Oscar R. Benavides, Sanjana Roy +9 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0.104DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433.v1

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

(2023)10.1158/1078-0432.c.6530583.v1

N/A

0DataRank · unranked

0 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Data from Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

(2023)10.1158/1078-0432.c.6530100.v1

Top 100%

0DataRank

Top 100%0 citations

Victoria Wang, Rebecca S. Heist, Scott Kopetz, Edith P. Mitchell, James A. Zwiebel +19 more

Data from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

(2023)10.1158/2159-8290.c.6549433.v1

N/A

0DataRank · unranked

0 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu‐Chin Fu +29 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1

N/A

0DataRank · unranked

0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3625

N/A

0DataRank · unranked

0 citations

Greg Yothers, Scott Kopetz, Shannon L. Puhalla, Peter C. Lucas, Atif Iqbal +8 more

DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.10.561733

N/A

0DataRank · unranked

0 citations

Xiaoqian Liu, Xuesen Cheng, Yujie Jiang, Shuangxi Ji, Qingnan Liang +12 more

New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis

Research Square(2023)10.21203/rs.3.rs-3439308/v1

N/A

0DataRank · unranked

0 citations

Harufumi Maki, Anuj Verma, Riham Katkhuda, Gayathri Anandappa, Renganayaki Pandurengan +11 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models

Advanced Science(2024)10.1002/advs.202303379

N/A

0DataRank · unranked

14 citations

Ergang Wang, John B. Mantyh, Gabrielle Rupprecht, Marcos Negrete, Golshid Sanati +24 more

Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-24-0624

N/A

0DataRank · unranked

5 citations

Claudia A. Collier, John Paul M. Gorley, Sarah Colijn, Maygan K. McFarlin, Spencer C. Solberg +4 more

New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis

BJC Reports(2024)10.1038/s44276-024-00056-8

N/A

0DataRank · unranked

2 citations

Harufumi Maki, Anuj Verma, Riham Katkhuda, Gayathri Anandappa, Renganayaki Pandurengan +12 more

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS -mutated colorectal cancer

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359241303302

N/A

0DataRank · unranked

3 citations

Fan Fan, Reid T. Powell, Yong Sung Park, Clifford Stephan, Scott Kopetz +3 more

Tumoral microbial and pathway alterations associated with young-onset rectal cancer and its response to therapy.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.3_suppl.160

N/A

0DataRank · unranked

2 citations

Ashish Damania, Jumanah Alshenaifi, Pranoti Sahasrabhojane, Oliver Peacock, Jillian Losh +9 more

A Gold Standard-Derived Modular Barcoding Approach to Cancer Transcriptomics

Cancers(2024)10.3390/cancers16101886

N/A

0DataRank · unranked

0 citations

Mohamad Karim Koleilat, Jason Roszik, Man Kam Kwong, Zhong Lin Wang, Dipen M. Maru +3 more

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS -mutated colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.05.611458

N/A

0DataRank · unranked

0 citations

Fan Fan, Reid T. Powell, Yong Park, Clifford Stephan, Scott Kopetz +3 more

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Annals of Oncology(2025)10.1016/j.annonc.2025.01.020

N/A

0DataRank · unranked

51 citations

Ferran Fece de la Cruz, W. Marston Linehan, Christine M. Parseghian, Jonathan Kim, Hiroyuki Matsubara +19 more

Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest

Cancer Cell(2025)10.1016/j.ccell.2025.09.010

N/A

0DataRank · unranked

26 citations

Falk Ponath, Victor A. Ajisafe, Clara R. Becker, Andrew G. Kempchinsky, Martha A. Zepeda‐Rivera +16 more

Mutational and co-mutational landscape of early onset colorectal cancer

Biomarkers(2025)10.1080/1354750x.2024.2447089

N/A

0DataRank · unranked

24 citations

Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G. White, John Paul Shen +14 more

Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2310

N/A

0DataRank · unranked

21 citations

Alvaro G. Paula, David Molkentine, Laura D. Hover, Monique B. Nilsson, Natalie I. Vokes +17 more

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3133

N/A

0DataRank · unranked

16 citations

Seong-Woo Bae, Jennifer G. Whisenant, Gregory D. Ayers, Quanhu Sheng, Todd E. Peterson +15 more

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0614

N/A

0DataRank · unranked

12 citations

Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra +19 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

Communications Medicine(2025)10.1038/s43856-024-00728-z

N/A

0DataRank · unranked

6 citations

Heinz‐Josef Lenz, Gianluigi Pillonetto, Raúl Méndez-Giráldez, Hanna K. Sanoff, Reza Hadi +17 more

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102253

N/A

0DataRank · unranked

4 citations

Mitsunobu Takeda, Alexey V. Sorokin, Shuaitong Chen, Zecheng Yang, Xiaofei Wang +25 more

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal Cancer

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0002

N/A

0DataRank · unranked

3 citations

Jean-François Martini, Lincoln W. Pasquina, Brian Tunquist, Xiaosong Zhang, Fatima Khaiser +10 more

Functional modules predict cancer-relevant genetic interactions in mammalian cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.18.695201

N/A

0DataRank · unranked

1 citations

Veronica Gheorghe, Juihsuan Chou, Sabriyeh Alibai, Subin Kim, Nazanin Esmaeili Anvar +9 more

Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis

Translational Oncology(2025)10.1016/j.tranon.2025.102379

N/A

0DataRank · unranked

0 citations

Reed I. Ayabe, Mohammad A. Zeineddine, Fadl A. Zeineddine, Abdelrahman Yousef, Mahmoud Yousef +12 more

Novel treatment-specific causal biomarkers for colorectal cancer by omics integration

NAR Genomics and Bioinformatics(2025)10.1093/nargab/lqaf053

N/A

0DataRank · unranked

0 citations

Azam Yazdani, Raúl Méndez-Giráldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi +9 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

UNC Libraries(2025)10.17615/rbz3-7m15

N/A

0DataRank · unranked

0 citations

Scott Kopetz, Rashid, Naim U, Mark J. Ratain, Esmat Samiei, Federico Innocenti +18 more

Supplementary Figure from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.22431731

N/A

0DataRank · unranked

0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling

Gastroenterology(2020)10.1053/j.gastro.2020.08.018

N/A

0DataRank · unranked

132 citations

Mihnea P. Dragomir, Linda Fabris, Recep Bayraktar, Erik Knutsen, Xu Liu +43 more

Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract

Genes(2020)10.3390/genes11060645

N/A

0DataRank · unranked

70 citations

Scott Kopetz, Eduardo Vilar, John Paul Shen, Ken Chen, Anirban Maitra +1 more

Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1024

N/A

0DataRank · unranked

43 citations

Benny Johnson, Laveniya Kugathasan, Van K. Morris, Kanwal Raghav, Lucas Swanson +9 more

Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer

Clinical Colorectal Cancer(2020)10.1016/j.clcc.2020.02.001

N/A

0DataRank · unranked

2 citations

Miguel Alcaide, James T. Topham, Benny Johnson, Ryan D. Morin, Jenny E. Chu +11 more

Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.08.033001

N/A

0DataRank · unranked

21 citations

Scott Kopetz, Eduardo Vilar, John Paul Shen, Ken Chen, Anirban Maitra +1 more

NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps261

N/A

0DataRank · unranked

17 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.306795

N/A

0DataRank · unranked

5 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Matthew D. Montierth, Shuai Guo +32 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4121

N/A

0DataRank · unranked

4 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Consensus molecular subtypes (CMS) as a marker for treatment and disease biology in metastatic colorectal cancer (CRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4089

N/A

0DataRank · unranked

2 citations

Preeti Kanikarla Marie, Amir Mehrvarz Sarshekeh, Van K. Morris, Dzifa Y. Duose, Baili Zhang +6 more

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin

UNC Libraries(2020)10.17615/kke1-de47

N/A

0DataRank · unranked

0 citations

Thomas LaFramboise, Michael S. Lee, Cathy Eng, David R. Fogelman, Stanley R. Hamilton +14 more

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration

UNC Libraries(2020)10.17615/mbqx-8p95

N/A

0DataRank · unranked

0 citations

Gabriel Lopez‐Berestein, Chang Gong Liu, Su Youn Nam, Jing Yi, Manel Esteller +43 more

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer

UNC Libraries(2020)10.17615/cgjy-ks12

N/A

0DataRank · unranked

0 citations

Michael S. Lee, Stanley R. Hamilton, Zhi-Qin Jiang, Jeffrey S. Morris, Scott Kopetz +7 more

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2404

N/A

0DataRank · unranked

52 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer

Gastroenterology(2021)10.1053/j.gastro.2021.03.022

N/A

0DataRank · unranked

39 citations

Frederick S. Robinson, Rosalba Minelli, Hideo Tomihara, Bahar Salimian Rizi, Johnathon L. Rose +30 more

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0180

N/A

0DataRank · unranked

39 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer

Journal of the American College of Surgeons(2021)10.1016/j.jamcollsurg.2021.05.027

N/A

0DataRank · unranked

39 citations

Scott Kopetz, Lawrence N. Kwong, Lianchun Xiao, Jeffrey S. Morris, Hop S. Tran Cao +5 more

Going with the Flow: The Promise of Plasma-Only Circulating Tumor DNA Assays

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2181

N/A

0DataRank · unranked

18 citations

Scott Kopetz, Alisha Bent

Phase II trial of bintrafusp alfa in patients with metastatic MSI-H cancers following progression on immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.79

N/A

0DataRank · unranked

15 citations

Michael Lam, Xuemei Wang, Michael J. Overman, Benny Johnson, Bryan K. Kee +7 more

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3618

N/A

0DataRank · unranked

7 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer:NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps148

N/A

0DataRank · unranked

5 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

Research Square(2021)10.21203/rs.3.rs-600171/v1

N/A

0DataRank · unranked

2 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Matthew D. Montierth, Shuai Guo +32 more

Phase II/III study of Circulating tumOr DNA as a predictive BiomaRker in Adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3622

N/A

0DataRank · unranked

2 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Epigenetic regulation of the Wnt-signaling pathway in CIMP-H BRAFV600E mCRC.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.110

N/A

0DataRank · unranked

0 citations

Stefania Napolitano, Van K. Morris, Kunal Rai, John Paul Shen, Jennifer S. Davis +8 more

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

Cancer Research(2022)10.1158/0008-5472.can-22-0198

N/A

0DataRank · unranked

81 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003633

N/A

0DataRank · unranked

55 citations

Qing Yang, Wendong Zhang, Hongwei Du, Yu‐Hui Chen, Qingnan Zhao +10 more

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts

Frontiers in Oncology(2022)10.3389/fonc.2022.994333

N/A

0DataRank · unranked

20 citations

Alexey V. Sorokin, Lea Bitner, Rebecca Aden, Michael Lam, Ganiraju C. Manyam +8 more

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Scientific Reports(2022)10.1038/s41598-022-05193-z

N/A

0DataRank · unranked

9 citations

Argun Akçakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen +12 more

Truncal Dynamics May Trump: Serial ctDNA to Predict Early Therapeutic Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2793

N/A

0DataRank · unranked

1 citations

Scott Kopetz, Christine M. Parseghian, Madhulika Eluri

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520

N/A

0DataRank · unranked

9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

Circulating tumor DNA dynamics on front-line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: A biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.193

N/A

0DataRank · unranked

4 citations

Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz +2 more

Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3647

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps233

N/A

0DataRank · unranked

3 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120

N/A

0DataRank · unranked

1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Chromatin Remodeling in Patient-Derived Colorectal Cancer Models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.24.501300

N/A

0DataRank · unranked

1 citations

Ergang Wang, Gabrielle Rupprecht, John B. Mantyh, Marcos Negrete, Golshid Sanati +20 more

Encorafenib, cetuximab, and cytotoxic chemotherapy combinations in BRAFV600E CRC murine models.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.145

N/A

0DataRank · unranked

0 citations

Vincenzo De Falco, Claudia Prisco, Giulia Martini, Luigi Pio Guerrera, Valentina Belli +11 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1467

N/A

0DataRank · unranked

116 citations

Kyle A. LaBella, Yiyun Lin, Ping Xu, Rumi Lee, Cheng‐En Hsieh +14 more

Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0468

N/A

0DataRank · unranked

26 citations

Saikat Chowdhury, Mohammad A. Zeineddine, Fadl A. Zeineddine, Nicholas J. Hornstein, Oscar E. Villarreal +9 more

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340

N/A

0DataRank · unranked

15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps265

N/A

0DataRank · unranked

8 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zishuo Ian Hu +6 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

P-228 Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107

Annals of Oncology(2023)10.1016/j.annonc.2023.04.284

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zelan Hu +7 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps258

N/A

0DataRank · unranked

1 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps259

N/A

0DataRank · unranked

1 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

Data from Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress

(2023)10.1158/0008-5472.c.6499370.v1

N/A

0DataRank · unranked

0 citations

Donald P. Lesslie, Nikolas A. Dallas, Serk In Park, Marjorie Johnson, Nila U. Parikh +6 more

Data from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.c.6513959.v1

N/A

0DataRank · unranked

0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility

Gut(2020)10.1136/gutjnl-2019-318279

N/A

0DataRank · unranked

232 citations

Scott Kopetz, Jaffer A. Ajani, George A. Calin, Mihnea P. Dragomir

Data from Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

(2023)10.1158/1078-0432.c.6530100

Top 100%

0DataRank

Top 100%0 citations

Victoria Wang, Rebecca S. Heist, Scott Kopetz, Edith P. Mitchell, James A. Zwiebel +19 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

(2023)10.1158/1078-0432.c.6530583

N/A

0DataRank · unranked

0 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Data from Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

(2023)10.1158/1078-0432.c.6530073.v1

N/A

0DataRank · unranked

0 citations

Anthony Dowers, Dongsheng Tu, Derek J. Jonker, Daniel L. Edelstein, Hannah Quinn +11 more

Scott Kopetz

Indexed papers

Top data-sharing exemplar

Papers